Monthly Archives: December 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning the Sale of Exactech, Inc. to TPC Capital is Fair to Shareholders – EXAC

NEW YORK, NY / ACCESSWIRE / December 28, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Exactech, Inc. (“Exactech” or the “Company”) (NASDAQ: EXAC) stock prior to October 23, 2017.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Exactech to TPG Capital for $42 per share. Exactech founders Dr. Bill Petty and Betty Petty, as well as CEO David Petty, have agreed to vote their shares in favor of the merger. To learn more about the action and your rights, go to:

http://www.zlkdocs.com/EXAC-Info-Request-Form-ma-6164

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 485064

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per Share is Fair to Shareholders – ENTL

NEW YORK, NY / ACCESSWIRE / December 28, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Entellus Medical, Inc. (“Entellus” or the “Company”) (NASDAQ: ENTL) stock prior to December 7, 2017.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Entellus to Stryker Corporation (SYK) for $24 in cash per share. To learn more about the action and your rights, go to:

http://www.zlk.com/mna/entellus-medical-inc

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The investigation concerns whether the Board of Entellus breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction and whether Stryker Corporation is underpaying for Entellus shares, thus unlawfully harming Entellus shareholders.

Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 485063

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Novan, Inc. (NOVN) and Lead Plaintiff Deadline – January 2, 2018

NEW YORK, NY / ACCESSWIRE / December 28, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Novan, Inc. (“Novan” or the “Company”) (NASDAQ: NOVN) and certain of its officers, on behalf of a class who purchased or otherwise acquired Novan securities between September 26, 2016 and January 26, 2017 (the “Class Period”) and/or pursuant to its September 26, 2016 initial public offering (“IPO”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/novn.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Novan had initiated and conducted two identical Phase 3 clinical trials for its lead product candidate SB204; (2) in fact, the two SB204 Phase 3 clinical trials were not identical; and (3) consequently, Novan’s financial statements were materially false and misleading at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: www.bgandg.com/novn, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Novan, you have until January 2, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 482616

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against INC Research Holdings, Inc. (INCR) & Lead Plaintiff Deadline – February 2, 2018

NEW YORK, NY / ACCESSWIRE / December 28, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against of INC Research Holdings, Inc. (“INC Research” or the “Company”) (NASDAQ: INCR) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired INC Research securities between May 10, 2017, and November 9, 2017, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/incr.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

On August 1, 2017, INC Research and inVentiv Health, Inc. (“inVentiv Health”) announced the completion of a merger between the two companies. On November 9, 2017, INC Research reported its first financial results after combining with inVentiv Health. The Company’s combined results were negatively impacted by merger-related expenses, an impairment charge and increased amortization expenses. Following this news, INC Research stock dropped $16.35 per share, or 28.43%, to close at $41.15 on November 9, 2017. The stock price continued to drop over the next three trading sessions, closing on November 14, 2017 at $34.35 per share, a total decline of $23.15 per share, or 40.3%.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) the Merger was not providing the benefit that Defendants stated it would; (2) inVentiv was underperforming; (3) consequently, the Company’s 2017 financial performance would be negatively impacted; and (4) as a result of the foregoing, Defendants’ statements about INCR’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/incr or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in INC Research you have until February 2, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 483536

Neil Shekhter – The Benefits of Real Estate Investing in Los Angeles and Santa Monica

SANTA MONICA, CA / ACCESSWIRE / December 28, 2017 / Neil Shekhter, founder of NMS Properties, a Los Angeles and Santa Monica-based real estate firm, discusses the Benefits of Real Estate Investing in Los Angeles.

Real estate investing in Los Angeles is increasing at a staggering rate these days. More and more individuals are learning that real estate investments can offer wonderful earnings potential. Real estate investing is a process which has many attractive qualities that make it a viable money-producing opportunity according to Neil Shekhter. There are a number of benefits that go along with purchasing real estate investments and the following paragraphs will highlight some of these benefits. As you will see these attributes make it quite apparent why individuals are becoming interested in investment opportunities of this type.

Build Equity in the Property

Neil Shekhter explained that for those individuals who are looking to invest in Los Angeles real estate on a long-term scale, there are certain benefits to doing so. When individuals purchase real estate and hold onto it for awhile, they are ultimately able to build a good deal of equity in the home they are purchasing as an investment property. Equity is a beneficial aspect for the homeowners as the more equity a property has, the more that it adds to the net worth thereof. This is an important and frequently cited reason why individuals do choose to invest in real estate and maintain the property as an investment for a long period of time thereafter.

Possible Tax Advantages

Another benefit of purchasing real estate in Los Angeles and Santa Monica for investment purposes is the possible tax advantages that one may receive as a result of owning the investment property. Depending on a variety of factors, individuals who own investment property may just see some gracious tax advantages as a result. Therefore, individuals may be more than ready to invest in real estate once they have looked into possible tax advantages that result from engaging in a transaction of this type.

High Rate of Return on the Sale of the Property

When the investment property is sold somewhere down the road, the homeowners will most likely see a high rate of return on the sale of the property. Depending on the market at the time of the purchase and sale, this rate of return may be more than generous when one looks at the profit margin. Some factors to consider if looking to purchase property and sell it within a short period of time after the initial purchase include current market for property sales, renovations and upkeep necessary to get the property ready for the sale and the ability to hold on to the property longer if a sale does not come as quickly as one had expected. If one has considered all of these possibilities and still feels that they will be able to sell the property quickly, then this is a wonderful benefit of real estate investment shares per Neil Shekhter.

Lease the Property to Tenants

While some real estate investors in Los Angeles choose to purchase the property and then sell it shortly thereafter, there are other individuals who have a different reason for purchasing investment properties and wish to obtain a profit by other means. These individuals are ones who prefer to purchase the property and then lease it out to tenants. By doing so, the homeowners are able to pay for any mortgage which may be present on the property plus receive any additional income from leasing the property to tenants.

Investing in real estate is a wonderful way to gain equity in a piece of property, take advantage of possible tax benefits and maybe even make a considerable profit from the sale of the property once the individual feels like doing so. These are some of the many reasons why individuals are purchasing real estate as investment property and current low interest rates make now a perfect time to buy. The benefits of real estate investing are difficult to pass up, so go ahead and find your first real estate investment property in LA!

Launching NMS Properties in 1988, Neil Shekhter assumed the role of CEO in January 1995. The real estate management company focuses on multi-family and mixed-use properties in the Greater Los Angeles area and in Santa Monica. At present, NMS properties manages more than 70 properties.

Neil Shekhter – Founder and CEO of NMS
Apartments For Rent In Los Angeles NMS Residential: http://www.nmsresidential.com
NMS Properties – Real Estate Management Firm: http://www.nmsproperties.com

Contact Information:

Neil@neilshekhter.com
info@neilshekhter.com

SOURCE: NMS Properties, Inc.

ReleaseID: 485029

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Acorda Therapeutics, Inc. (ACOR) and Lead Plaintiff Deadline – January 17, 2018

NEW YORK, NY / ACCESSWIRE / December 28, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Acorda Therapeutics, Inc. (“Acorda” or the “Company”) (NASDAQ: ACOR) and certain of its officers, on behalf of a class who purchased Acorda securities between April 18, 2016, and November 14, 2017, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/acor.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.

Acorda is a biotechnology company with a focus on the identification, development, and commercialization of therapies for neurological disorders. On January 19, 2016, Acorda announced an agreement to acquire Biotie Therapies Corporation (“Biotie”) for approximately $363 million (the “Biotie Acquisition”). In its press release announcing the Biotie Acquisition, Acorda advised investors, inter alia, that the Company “will obtain worldwide rights to tozadenant, an oral adenosine A2a receptor antagonist currently in Phase 3 development in Parkinson’s disease (PD).” On April 18, 2016, Acorda acquired approximately 93% of the fully diluted capital stock of Biotie. In September 2016, Acorda completed the Biotie Acquisition.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) tozadenant entailed significant undisclosed safety risks; (2) accordingly, the Company had overstated tozadenant’s approval prospects and commercial viability; (3) for the foregoing reasons, the Company had likewise overstated the benefits of the Biotie Acquisition; and (4) consequently, Acorda’s shares traded at artificially inflated prices during the Class Period.

On November 15, 2017, Acorda disclosed the deaths of several patients in the Company’s final-stage studies of tozadenant. Acorda advised investors that it had paused new enrollment in the drug’s long-term safety studies, pending further discussion with the independent Data Safety Monitoring Board and the U.S. Food and Drug Administration. Following this news, Acorda stock dropped $11.20 per share, or 39.72%, to close at $17.00 on November 15, 2017.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: www.bgandg.com/acor, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Acorda, you have until January 17, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 482341

The Citizens Commission on Human Rights Continues to Fight Mental Health Abuse

CCHR, a mental health watchdog dedicated to the protection of children, relaunched a campaign to stop the unjust Baker Acting of minors in response to the involuntary examinations of over 32,000 children across Florida in 2016.

Clearwater, United States – December 28, 2017 /PressCable/

Having educated tens of thousands of Floridians on the mental health law in just over the past two years, the Citizens Commission on Human Rights (CCHR), is relaunching their campaign to protect children from unnecessary involuntary psychiatric examination

The Florida chapter of CCHR, a non-profit mental health watchdog that exposes human rights violations and is dedicated to the protection of children, applauded state lawmakers earlier this year when the mental health law was amended to afford better protection for children who have been sent for involuntary psychiatric examination. This law commonly referred to as the Baker Act, allows a child to be taken into custody and transported by law enforcement to a psychiatric facility without parental knowledge or consent. Until recently once sent, a child could be detained for up to 72 hours for psychiatric examination. The amendment to the Baker Act now requires that the initial examination to determine if the child meets the criteria to be held under the law be initiated within 12 hours after the child’s arrival at a receiving facility.

Originally launched in late 2015 with the purpose of stopping the unjust Baker Acting of children, the campaign was begun in response to the alarming number of children being sent for involuntary psychiatric examination in Florida. The original intent of the Baker Act, named after Maxine Baker, the former State Representative from Miami who sponsored the Act, was to ensure patient rights and prevent abuse, however the Annual Report of Baker Act Data, revealed in March of this year a continuing surge of minor Baker Acts with over 32,000 children Baker Acted in 2016.

“In our opinion and based on existing law, a parent should be brought into the process before something as traumatic as a Baker Act is initiated on a child,” stated Diane Stein, President of CCHR Florida. “This is not being done and we believe this is a violation of the rights of the parent and the child.”

A primary focus of the campaign is public education and since the launch CCHR has educated close to 160,000 families on their rights under the mental health law. Anyone living in Florida who is interested in protecting children from abusive Baker Acting may obtain more information on this campaign by contacting CCHR at 727-442-8820 or visiting the center at 109 N. Fort Harrison Ave in Clearwater, Florida.

About CCHR: Initially established by the Church of Scientology and renowned psychiatrist Dr. Thomas Szasz in 1969, CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. It was L. Ron Hubbard, the founder of Scientology, who brought the terror of psychiatric imprisonment to the notice of the world. In March 1969, he said, “Thousands and thousands are seized without process of law, every week, over the ‘free world’ tortured, castrated, killed. All in the name of ‘mental health.’” For more information please visit www.cchrflorida.org

The Baker Act The Florida Mental Health Act Fiscal Year 2015/2016 Annual Report, Released March 2017 – Prepared for the Florida Department of Children and Families by the Baker Act Reporting Center – usf.edu/cbcs/baker-act/documents/annual_report.pdf

Contact Info:
Name: Diane Stein
Email: Send Email
Organization: Citizens Commission on Human Rights of Florida
Address: 109 North Fort Harrison Avenue, Clearwater, Florida 33755, United States
Phone: +1-727-442-8820

For more information, please visit http://www.cchrflorida.org/

Source: PressCable

Release ID: 281982

Tattoo Removal 2017 Global Market to Reach USD 4,794.9 million and Growing at CAGR of 15.6% by 2023

WiseGuyReports.Com Publish a New Market Research Report On – “Tattoo Removal 2017 Global Market to Reach USD 4,794.9 million and Growing at CAGR of 15.6% by 2023”.

Pune, India – December 28, 2017 /MarketersMedia/

Tattoos are permanent markings in the skin. The procedures are inclusive of injecting ink via needles into the dermis. In recent years, tattoos became an artistic, attractive, and expressive tool. A majority of the people who are getting their skin inked are of 18 to 24 years of age group. Changing trends and poor artwork followed by strict corporate employment policies regarding tattoos may lead people to get tattoo removed. Such prevailing factors are the major drivers for the market growth. Sometimes tattoo removal happens when the people’s interest changes in hands with the trend, i.e., when they want to get the tattoo removed, making space for the new tattoo. Thus, huge credits can be attributed to this factor in growing the tattoo removal market, as the number of people wanting to remove the tattoo for the getting the new one is quite high. Moreover, military recruitment policies regarding tattoos and increasing errors in digital body sensing devices leading to incorrect results also facilitates the market growth during the forecast period. However, the market growth can be restricted by factors like excessive cost of the laser based procedure, scars left after the surgical removal and high number of sittings for laser treatment during the forecast period. The procedures of tattoo removal are expensive. A majority of the tattoo removal procedures are based on the laser therapeutics. However, it is notable that the tattoo removal laser therapy is time consuming and is followed by multiple sessions, depending on the size and the color of the tattoo. The more will be the number of sessions, the higher will be the cost of treatment.

The global tattoo removal market is expected to reach USD 4,794.9 million by 2023 at a CAGR of 15.6% during the forecasted period.

The global tattoo removal market is segmented on the basis of therapeutic method, end user and regions. On the basis of therapeutic method, the market is segmented into laser therapy, surgical method, topical creams, and others. The laser therapy segment market accounts the largest share and is expected to reach USD 3,247.7 million by 2023 from USD 970.8 million in 2016 at the CAGR of 15.9% for the forecasted periods.
On the basis on end users, the global tattoo removal market is segmented into laser center, and dermatology clinic, and others. Laser center segment dominated the global market in 2016 and accounted for USD 895.2 million.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/2690983-global-tattoo-remova-market-analysis-forecast-2017-to-2023

For more information or any query mail at sales@wiseguyreports.com

On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific and the Middle East & Africa. North America has the dominating market for safety tattoo removal. The tattoo removal market for North America is estimated at USD 382.3 million in 2016 and expected to reach by USD 1,312.4 million by 2023 at a fastest CAGR of 16.3%.

Key Players
The leading market players in the global tattoo removal market include: Astanza, Cutera, Inc., CynoSure, Dimyth, Lutronic, Syneron Medical Ltd, Quanta System S.p.A., and others.

Study objectives

• To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global tattoo removal market.
• To provide insights about factors influencing and affecting the market growth.
• To provide historical and forecast revenue of the market segments and sub-segments with respect to – regional markets and their countries
• To provide historical and forecast revenue of the market segments based on by treatment method, by end user, by region for global tattoo removal market.
• To provide strategic profiling of key players in the market, comprehensively analysing their market share, and drawing a competitive landscape for the market.

Target Audience
• Pharmaceutical Companies
• Pharmaceutical Suppliers
• Potential investors
• Key executive (CEO and COO) and strategy growth manager
• Research companies

Key Findings

• Laser Therapy accounted for the largest market share in 2016, with a market value of USD 970.8 million and is projected to grow at a CAGR of 15.9% during the forecast period. Surgical Method was the second-largest market, valued at USD 402.7 million in 2016; it is projected to grow at the CAGR of 15.6%.

• The global tattoo removal market for dermatology clinics is projected to reach USD 1,464 million at the CAGR of 16.1% during 2017 to 2023.

• U.S. accounted for the largest market share in 2016, with a market value of USD 457.5 million and is projected to grow at a CAGR of 16.2% during the forecast period. Canada was the second-largest market, valued at USD 124.6 million in 2016; it is projected to grow at a CAGR of 15.0%

The reports also covers regional analysis
• North America
o US
o Canada
• Europe
o Germany
o France
o U.K.
o Italy
o Spain
o Rest of Europe
o Eastern Europe
• Asia Pacific
o Japan
o China
o India
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa

Ask Query @ https://www.wiseguyreports.com/enquiry/2690983-global-tattoo-remova-market-analysis-forecast-2017-to-2023

Table Of Contents – Major Key Points

1 Report Prologue 9

2 Market Introduction 13
2.1 Definition 13
2.2 Scope of Study 13
2.3 Research Objective 13
2.4 Assumptions & Limitations 14
2.4.1 Assumptions 14
2.4.2 Limitations 14
2.5 Market Structure 14

3 Research Methodology 15
3.1 Research Process 15
3.2 Primary Research 16
3.3 Secondary Research 16

4 Market Dynamics 17
4.1 Introduction 17
4.2 Drivers 18
4.2.1 Strict corporate employment policies regarding tattoos 18
4.2.2 Military recruitment policies regarding tattoos 18
4.2.3 Increasing errors in digital body sensing devices leading to incorrect results. 18
4.2.4 Changing trends, poor artwork may lead people to get tattoo removed. 19
4.3 Restraints 20
4.3.1 Excessive cost of the Laser procedure forces people to look for substitute treatments. 20
4.3.2 Number of sittings for laser treatment 20
4.3.3 Scars left after the surgical removal of tattoo 20
4.4 Opportunities 21
4.4.1 Development of the injectable solutions 21
4.4.2 Improvement in the Laser Technology 21
4.4.3 Licensing the technology with local players to reach untapped regions 21

Continue…….

Buy 1-User PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2690983

For more information or any query mail at sales@wiseguyreports.com

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WiseGuy Research Consultants Pvt Ltd.
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028
Phone: +1-646-845-9349

Source URL: https://marketersmedia.com/tattoo-removal-2017-global-market-to-reach-usd-4794-9-million-and-growing-at-cagr-of-15-6-by-2023/282292

For more information, please visit https://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 282292

Candle Market 2017 Global Trends, Market Share, Industry Size, Growth, Opportunities and Forecast to 2023

Candle Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023

Pune, India – December 28, 2017 /MarketersMedia/

Summary

WiseGuyReports.com adds “Candle Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Candle Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Candle Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

A candle is wax with an ignitable wick embedded that provides light, and in some cases, a fragrance. It can also be used to provide heat, or as a method of keeping time.

Global Candle market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

By Company
Blyth
Jarden Corp
Colonial Candle
S. C. Johnson & Son
Chesapeake Bay Candle
Langley/Emprire Candle
Lancaster Colony
Armadilla Wax Works
Dianne’s Custom Candles
Bolsius
Gies
Vollmar
Kingking
Talent
Zhong Nam
Pintian Wax
Everlight
Allite
Candle-lite

Request a Sample Report @  https://www.wiseguyreports.com/sample-request/2628335-2015-2023-world-candle-market-research-report-by-product-type-end

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)

By Type
Animal wax candles
Vegetable wax candles
Paraffin wax candles
Synthetic wax candles

By End-User / Application
Traditional Field
Craft Field

At any Query @ https://www.wiseguyreports.com/enquiry/2628335-2015-2023-world-candle-market-research-report-by-product-type-end

Table of Contents 

1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs

5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa

….

11 Market Forecast
11.1 Global Market Forecast (2018-2023)
11.2 Market Forecast by Regions (2018-2023)
11.3 Market Forecast by Type (2018-2023)
11.4 Market Forecast by End-Use / Application (2018-2023)

12 Key Manufacturers
12.1 Blyth
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Jarden Corp
12.2.1 Company Overview
12.2.2 Product and End-User / Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 Colonial Candle
12.3.1 Company Overview
12.3.2 Product and End-User / Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 S. C. Johnson & Son
12.4.1 Company Overview
12.4.2 Product and End-User / Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 Chesapeake Bay Candle
12.5.1 Company Overview
12.5.2 Product and End-User / Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 Langley/Emprire Candle
12.12.1 Company Overview
12.12.2 Product and End-User / Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 Lancaster Colony
12.7.1 Company Overview
12.7.2 Product and End-User / Application
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 Armadilla Wax Works
12.8.1 Company Overview
12.8.2 Product and End-User / Application
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 Dianne’s Custom Candles
12.9.1 Company Overview
12.9.2 Product and End-User / Application
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.10 Bolsius
12.10.1 Company Overview
12.10.2 Product and End-User / Application
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.11 Gies
12.12 Vollmar
12.13 Kingking
12.14 Talent
12.15 Zhong Nam
12.16 Pintian Wax
12.17 Everlight
12.18 Allite
12.19 Candle-lite 

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2628335

Continued….

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers, Magarpatta Road, Hadapsar, Pune – 411028
Phone: +1-646-845-9349 (US), +44 208 133 9349 (UK)

Source URL: https://marketersmedia.com/candle-market-2017-global-trends-market-share-industry-size-growth-opportunities-and-forecast-to-2023/282263

For more information, please visit https://www.wiseguyreports.com/sample-request/2628335-2015-2023-world-candle-market-research-report-by-product-type-end

Source: MarketersMedia

Release ID: 282263

Global Yerba Mate Market 2017 Size, Share, Growth, Status, Type and Application, Segmentation, Forecast by 2023

Yerba Mate Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023

Pune, India – December 28, 2017 /MarketersMedia/

Summary

WiseGuyReports.com adds “Yerba Mate Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Yerba Mate Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Yerba Mate Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Yerba mate is made from the naturally caffeinated and nourishing leaves of the celebrated South American rainforest holly tree (Ilex paraguariensis). Yerba Mate has the “strength of coffee, the health benefits of tea, and the euphoria of chocolate” all in one beverage.  Of the six commonly used stimulants in the world: coffee, tea, kola nut, cocoa and guarana, yerba mate triumphs as the most balanced, delivering both energy and nutrition. Yerba mate is the national drink of Argentina, Paraguay, Uruguay, and Southern Brazil where it is consumed 6 to 1 over coffee.

Global Yerba Mate market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

By Company
Las Marías
Amanda
Andresito
Molinos
Canarias
La Tranquera
Playadito
Santo Pipó
Lauro Raatz
Barão
Aguantadora
Kraus Yerba Mate
CBSe
Romance
Rosamonte
Selecta
La Virginia
Triunfo
Mate Factor
Wisdom Natural
ECOTEAS

Request a Sample Report @  https://www.wiseguyreports.com/sample-request/2627834-2015-2023-world-yerba-mate-market-research-report-by-product-type

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)

By Type
Normal Yerba Mate
Organic Yerba Mate

By End-User / Application
50 age

At any Query @ https://www.wiseguyreports.com/enquiry/2627834-2015-2023-world-yerba-mate-market-research-report-by-product-type

Table of Contents 

1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs

5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa

….

12 Key Manufacturers
12.1 Las Marías
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Amanda
12.2.1 Company Overview
12.2.2 Product and End-User / Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 Andresito
12.3.1 Company Overview
12.3.2 Product and End-User / Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 Molinos
12.4.1 Company Overview
12.4.2 Product and End-User / Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 Canarias
12.5.1 Company Overview
12.5.2 Product and End-User / Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 La Tranquera
12.12.1 Company Overview
12.12.2 Product and End-User / Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 Playadito
12.7.1 Company Overview
12.7.2 Product and End-User / Application
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 Santo Pipó
12.8.1 Company Overview
12.8.2 Product and End-User / Application
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 Lauro Raatz
12.9.1 Company Overview
12.9.2 Product and End-User / Application
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.10 Barão
12.10.1 Company Overview
12.10.2 Product and End-User / Application
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.11 Aguantadora
12.12 Kraus Yerba Mate
12.13 CBSe
12.14 Romance
12.15 Rosamonte
12.16 Selecta
12.17 La Virginia
12.18 Triunfo
12.19 Mate Factor
12.20 Wisdom Natural
12.21 ECOTEAS 

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2627834

Continued….

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers, Magarpatta Road, Hadapsar, Pune – 411028
Phone: +1-646-845-9349 (US), +44 208 133 9349 (UK)

Source URL: https://marketersmedia.com/global-yerba-mate-market-2017-size-share-growth-status-type-and-application-segmentation-forecast-by-2023/282291

For more information, please visit https://www.wiseguyreports.com/sample-request/2627834-2015-2023-world-yerba-mate-market-research-report-by-product-type

Source: MarketersMedia

Release ID: 282291